56 related articles for article (PubMed ID: 27458854)
1. Combination of DKK1 and AFP improves diagnostic accuracy of hepatocellular carcinoma compared with either marker alone.
Erdal H; Gül Utku Ö; Karatay E; Çelik B; Elbeg Ş; Doğan İ
Turk J Gastroenterol; 2016 Jul; 27(4):375-81. PubMed ID: 27458854
[TBL] [Abstract][Full Text] [Related]
2. OPN is a promising serological biomarker for hepatocellular carcinoma diagnosis.
Zhu M; Zheng J; Wu F; Kang B; Liang J; Heskia F; Zhang X; Shan Y
J Med Virol; 2020 Dec; 92(12):3596-3603. PubMed ID: 32043608
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic Performance of Alpha-Fetoprotein, Protein Induced by Vitamin K Absence, Osteopontin, Dickkopf-1 and Its Combinations for Hepatocellular Carcinoma.
Jang ES; Jeong SH; Kim JW; Choi YS; Leissner P; Brechot C
PLoS One; 2016; 11(3):e0151069. PubMed ID: 26986465
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic Value of Glypican-3 for Hepatocellular Carcinomas.
El-Saadany S; El-Demerdash T; Helmy A; Mayah WW; El-Sayed Hussein B; Hassanien M; Elmashad N; Fouad MA; Basha EA
Asian Pac J Cancer Prev; 2018 Mar; 19(3):811-817. PubMed ID: 29582639
[TBL] [Abstract][Full Text] [Related]
5. Anti-BIRC5 autoantibody serves as a valuable biomarker for diagnosing AFP-negative hepatocellular carcinoma.
Li Q; Liu H; Wang H; Xiong W; Dai L; Zhang X; Wang P; Ye H; Shi J; Fang Z; Wang K
PeerJ; 2024; 12():e17494. PubMed ID: 38832035
[TBL] [Abstract][Full Text] [Related]
6. The predictive value of serum Dickkopf-1, Dickkopf-3 level to coronary artery disease and acute coronary syndrome.
Xu P; Cao Y; Zhang S; Liu X; Zhang M; Zhang C
Int J Cardiol; 2024 May; 403():131887. PubMed ID: 38382851
[TBL] [Abstract][Full Text] [Related]
7. Midkine (MDK) in Hepatocellular Carcinoma: More than a Biomarker.
Christou C; Stylianou A; Gkretsi V
Cells; 2024 Jan; 13(2):. PubMed ID: 38247828
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic accuracy of serum derived exosomes for hepatocellular carcinoma: a systematic review and meta-analysis.
Tiyuri A; Baghermanesh SS; Davatgaran-Taghipour Y; Eslami SS; Shaygan N; Parsaie H; Barati M; Jafari D
Expert Rev Mol Diagn; 2023; 23(11):971-983. PubMed ID: 37715364
[TBL] [Abstract][Full Text] [Related]
9. Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer's Disease Pathology.
Shi L; Winchester LM; Liu BY; Killick R; Ribe EM; Westwood S; Baird AL; Buckley NJ; Hong S; Dobricic V; Kilpert F; Franke A; Kiddle S; Sattlecker M; Dobson R; Cuadrado A; Hye A; Ashton NJ; Morgan AR; Bos I; Vos SJB; Ten Kate M; Scheltens P; Vandenberghe R; Gabel S; Meersmans K; Engelborghs S; De Roeck EE; Sleegers K; Frisoni GB; Blin O; Richardson JC; Bordet R; Molinuevo JL; Rami L; Wallin A; Kettunen P; Tsolaki M; Verhey F; Lleó A; Alcolea D; Popp J; Peyratout G; Martinez-Lage P; Tainta M; Johannsen P; Teunissen CE; Freund-Levi Y; Frölich L; Legido-Quigley C; Barkhof F; Blennow K; Rasmussen KL; Nordestgaard BG; Frikke-Schmidt R; Nielsen SF; Soininen H; Vellas B; Kloszewska I; Mecocci P; Zetterberg H; Morgan BP; Streffer J; Visser PJ; Bertram L; Nevado-Holgado AJ; Lovestone S
J Alzheimers Dis; 2020; 77(3):1353-1368. PubMed ID: 32831200
[TBL] [Abstract][Full Text] [Related]
10. Multi‑layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/β‑catenin signaling activation (Review).
Katoh M
Int J Mol Med; 2018 Aug; 42(2):713-725. PubMed ID: 29786110
[TBL] [Abstract][Full Text] [Related]
11. Updating the Clinical Application of Blood Biomarkers and Their Algorithms in the Diagnosis and Surveillance of Hepatocellular Carcinoma: A Critical Review.
Shahini E; Pasculli G; Solimando AG; Tiribelli C; Cozzolongo R; Giannelli G
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901717
[TBL] [Abstract][Full Text] [Related]
12. Metabolomic biomarkers for the diagnosis and post-transplant outcomes of AFP negative hepatocellular carcinoma.
Lin Z; Li H; He C; Yang M; Chen H; Yang X; Zhuo J; Shen W; Hu Z; Pan L; Wei X; Lu D; Zheng S; Xu X
Front Oncol; 2023; 13():1072775. PubMed ID: 36845695
[TBL] [Abstract][Full Text] [Related]
13. Generation of An Induced Pluripotent Stem Cell Line from Human Liver Fibroblasts from A Patient with Combined Hepatocellular-Cholangiocarcinoma.
Ahn H; Ryu J; Lee J; Mun SJ; Hong Y; Shin Y; Chung K; Son MJ
Cell J; 2022 Mar; 24(3):133-139. PubMed ID: 35451583
[TBL] [Abstract][Full Text] [Related]
14. Dickkopf Proteins and Their Role in Cancer: A Family of Wnt Antagonists with a Dual Role.
Giralt I; Gallo-Oller G; Navarro N; Zarzosa P; Pons G; Magdaleno A; Segura MF; Sánchez de Toledo J; Moreno L; Gallego S; Roma J
Pharmaceuticals (Basel); 2021 Aug; 14(8):. PubMed ID: 34451907
[TBL] [Abstract][Full Text] [Related]
15. Abdominal ultrasound and alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.
Colli A; Nadarevic T; Miletic D; Giljaca V; Fraquelli M; Štimac D; Casazza G
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013346. PubMed ID: 33855699
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis Accuracy and Prognostic Significance of the Dickkopf-1 Protein in Gastrointestinal Carcinomas: Systematic Review and Network Meta-analysis.
Jiang X; Hui F; Qin X; Wu Y; Liu H; Gao J; Li X; Xu Y; Zhang Y
J Cancer; 2020; 11(24):7091-7100. PubMed ID: 33193872
[No Abstract] [Full Text] [Related]
17. Study of Dickkopf-1 (DKK-1) in patients with chronic viral hepatitis C-related liver cirrhosis with and without hepatocellular carcinoma.
Eldeeb MK; Magour GM; Bedair RN; Shamseya MM; Hammouda MA
Clin Exp Hepatol; 2020 Jun; 6(2):85-91. PubMed ID: 32728624
[TBL] [Abstract][Full Text] [Related]
18. Novel biomarkers for the management of chronic hepatitis B.
Inoue T; Tanaka Y
Clin Mol Hepatol; 2020 Jul; 26(3):261-279. PubMed ID: 32536045
[TBL] [Abstract][Full Text] [Related]
19. Serum Dickopff 1 as a Novel Biomarker in Hepatocellular Carcinoma Diagnosis and Follow Up After Ablative Therapy.
Younis YS; Alegaily HS; Elagawy W; Semeya AA; Abo-Amer YE; El-Abgeegy M; Mostafa SM; Elsergany HF; Abd-Elsalam S
Cancer Manag Res; 2019; 11():10555-10562. PubMed ID: 31908527
[TBL] [Abstract][Full Text] [Related]
20. The clinical efficacy and safety of kanglaite adjuvant therapy in the treatment of advanced hepatocellular carcinoma: A PRISMA-compliant meta-analysis.
Liu J; Liu X; Ma J; Li K; Xu C
Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31713581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
